In:
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, Journal of Bone Marrow Transplantation and Cellular Therapy, Vol. 4, No. 1 ( 2023-02-28), p. 178-
Abstract:
The document discuss key points in the management of patients with Myelodysplastic Disease, including therapeutic strategies, the role of new drugs available as well the Hematopoietic Stem Cell Transplantation. Other issues evaluated were importance of molecular alterations since diagnosis to prognosis, use of comprehensive geriatric assessment for patient's selection, individualization of treatment, donor selection for HSCT and the role of blasts % and molecular mutations for the appropriate diagnosis.
Type of Medium:
Online Resource
ISSN:
2675-374X
DOI:
10.46765/2675-374X.2023v4n1
DOI:
10.46765/2675-374X.2023v4n1p178
Language:
Unknown
Publisher:
Journal of Bone Marrow Transplantation and Cellular Therapy
Publication Date:
2023
Permalink